Cargando…

P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB

Detalles Bibliográficos
Autores principales: Murakhovskaya, Irina, Crivera, Concetta, Leon, Ann, Alemao, Evo, Anupindi, Vamshi Ruthwik, Dekoven, Mitch, Divino, Victoria, Lin, Iris, Shu, Cathye, Ebrahim, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430377/
http://dx.doi.org/10.1097/01.HS9.0000973660.04294.a8
_version_ 1785090948565303296
author Murakhovskaya, Irina
Crivera, Concetta
Leon, Ann
Alemao, Evo
Anupindi, Vamshi Ruthwik
Dekoven, Mitch
Divino, Victoria
Lin, Iris
Shu, Cathye
Ebrahim, Tarek
author_facet Murakhovskaya, Irina
Crivera, Concetta
Leon, Ann
Alemao, Evo
Anupindi, Vamshi Ruthwik
Dekoven, Mitch
Divino, Victoria
Lin, Iris
Shu, Cathye
Ebrahim, Tarek
author_sort Murakhovskaya, Irina
collection PubMed
description
format Online
Article
Text
id pubmed-10430377
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104303772023-08-17 P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB Murakhovskaya, Irina Crivera, Concetta Leon, Ann Alemao, Evo Anupindi, Vamshi Ruthwik Dekoven, Mitch Divino, Victoria Lin, Iris Shu, Cathye Ebrahim, Tarek Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430377/ http://dx.doi.org/10.1097/01.HS9.0000973660.04294.a8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Murakhovskaya, Irina
Crivera, Concetta
Leon, Ann
Alemao, Evo
Anupindi, Vamshi Ruthwik
Dekoven, Mitch
Divino, Victoria
Lin, Iris
Shu, Cathye
Ebrahim, Tarek
P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB
title P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB
title_full P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB
title_fullStr P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB
title_full_unstemmed P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB
title_short P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB
title_sort p1697: characteristics, treatment patterns and healthcare utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430377/
http://dx.doi.org/10.1097/01.HS9.0000973660.04294.a8
work_keys_str_mv AT murakhovskayairina p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab
AT criveraconcetta p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab
AT leonann p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab
AT alemaoevo p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab
AT anupindivamshiruthwik p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab
AT dekovenmitch p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab
AT divinovictoria p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab
AT liniris p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab
AT shucathye p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab
AT ebrahimtarek p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab